Table 1.
Group | No. of mice | No. of tumors/mouse |
Adenocarcinoma | Adenomaf |
||||
---|---|---|---|---|---|---|---|---|
Total | >1 mm | <1 mm | ++ + | ++ | + | |||
Control | 5 | 17.36 ± 3.04 | 5.89 ± 3.57 | 11.64 ± 0.70 | 3 | 2 | 0 | 0 |
Radiation only | 5 | 16.44 ± 2.71 | 5.28 ± 2.72 | 10.92 ± 3.83 | 2 | 0 | 1 | 2 |
Beclin1 only | 5 | 11.19 ± 1.21a,c | 3.28 ± 0.98 | 7.94 ± 1.51 | 1 | 1 | 2 | 0 |
Radiation + Beclin1 | 5 | 8.97 ± 0.56b,d,e | 2.92 ± 1.10 | 6.06 ± 1.61b | 0 | 0 | 0 | 2 |
Sixteen K-rasLA1 lung cancer model mice were randomly divided into four groups; control, radiation only, beclin1 only and radiation/beclin 1 combination. Animals were 17 weeks old at sacrifice. Lungs were collected, tumor numbers/sizes on the surface of lungs were counted, and fixed in 10% neutral buffered formalin for histological examination. Incidence and multiplicity of lung proliferative lesions were compared (mean ± SE).
aP < 0.05 compared with control group; bP < 0.01 compared with control group; cP < 0.05 compared with radiation only group; dP < 0.01 compared with radiation only group; eP < 0.05 compared with beclin1 only group; fgrades of adenoma: ++ + , severe; ++ , moderate; +, mild.